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Insulin Resistance
Na Xiao, Le-Le Yang, Yi-Lin Yang, Li-Wei Liu, Jia Li, Baolin Liu, Kang Liu, Lian-Wen Qi * and
Ping Li *
State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China
Endoplasmic reticulum (ER) stress, inflammation, and lipolysis occur simultaneously in
adipose dysfunction and contribute to insulin resistance. This study was designed to
investigate whether ginsenoside Rg5 could ameliorate adipose dysfunction and prevent
muscle insulin resistance. Short-term high-fat diet (HFD) feeding induced hypoxia with
ER stress in adipose tissue, leading to succinate accumulation due to the reversal of
succinate dehydrogenase (SDH) activity. Rg5 treatment reduced cellular energy charge,
suppressed ER stress and then prevented succinate accumulation in adipose tissue.
Succinate promoted IL-1β production through NLRP3 inflammasome activation and then
increased cAMP accumulation by impairing PDE3B expression, leading to increased
lipolysis. Ginsenoside Rg5 treatment suppressed NLRP3 inflammasome activation,
preserved PDE3B expression and then reduced cAMP accumulation, contributing
to inhibition of lipolysis. Adipose lipolysis increased FFAs trafficking from adipose
tissue to muscle. Rg5 reduced diacylglycerol (DAG) and ceramides accumulation,
inhibited protein kinase Cθ translocation, and prevented insulin resistance in muscle.
In conclusion, succinate accumulation in hypoxic adipose tissue acts as a metabolic
signaling to link ER stress, inflammation and cAMP/PKA activation, contributing to
lipolysis and insulin resistance. These findings establish a previously unrecognized role of
ginsenosides in the regulation of lipid and glucose homeostasis and suggest that adipose
succinate-associated NLRP3 inflammasome activation might be targeted therapeutically
to prevent lipolysis and insulin resistance.
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INTRODUCTION
Adipose tissue functions as a site for fat storage, whereas disordered fat storage andmobilization are
tightly associated with insulin resistance and diabetes. The elevated level of plasma free fatty acids
(FFAs) is often observed in individuals subject to insulin resistance and diabetes (Coppack et al.,
1992). The abnormal fat deposit has increased lipolytic ability, and therefore, enhanced delivery of
FFAs to the liver or muscle, leading to ectopic lipid deposition and insulin resistance.
It is generally accepted that adipose hypoxia is a result of increased fat mass size (Skurk et al.,
2007; Trayhurn, 2013; Muniyappa and Sowers, 2014). However, a recent study demonstrates that
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saturated fatty acids induce adipose hypoxia through increasing
oxygen consumption in adipocytes without alternation in the
fat mass size (Lee et al., 2014). This finding sheds new insight
into the impact of lipid challenge in adipose dysfunction. As
a cellular stress, hypoxia induces endoplasmic reticulum (ER)
stress in adipose tissue. Aside being a center for protein folding,
the ER functions as a major signal-transducing organelle to sense
cellular homeostasis. Cellular stress activates transmembrane
sensors, including inositol-requiring enzyme 1α (IRE1α), RNA-
dependent protein kinase-like ER kinase (PERK) and activating
transcription factor 6 (ATF6) to induce unfolded-protein
response or ER stress. ER stress is proposed to trigger oxidative
stress, inflammation and cell death in specialized cells or tissues,
and recent findings show that ER stress augments lipolysis in
adipose tissue (Deng et al., 2012; Bogdanovic et al., 2015).
Although hypoxia, ER stress, and lipolysis simultaneously occur
in adipose dysfunction (Kawasaki et al., 2012; Trayhurn, 2013),
the mechanisms and unifying framework for these events are not
yet fully understood.
As an important intermediate of the mitochondrial citric
acid cycle (CAC), succinate emerges as a metabolic signaling
mediator which is responsible for the adaptation of tissues to
hypoxic conditions. The conventional direction of succinate
dehydrogenase (SDH) in the CAC is to drive succinate toward
fumarate formation. However in ischemic heart, succinate
accumulation arises from reversal of SDH activity, a process
partially relative with the malate/aspartate shuttle (Chouchani
et al., 2014). As succinate accumulation induces ROS production
and tissue damage in ischemic heart, and increases hypoxia-
inducible factor-1α (HIF-1α) induction and IL-1β expression in
macrophages (Tannahill et al., 2013), it is tempting to know if
succinate acts as a metabolic signaling in hypoxic adipose tissue
dysfunction.
Ginseng root has been used for thousands of years in
traditional Chinese medicine. Ginsenosides are the major
bioactive constituents in ginseng root with beneficial effects on
the regulation of glucose and lipid metabolism (Shang et al.,
2008; Lee H. M. et al., 2012; Yuan et al., 2012). Ginsenoside Rg5
is the most abundant compound in steamed ginseng (Qi et al.,
2011) and its action in the regulation of metabolic homeostasis
is unknown. This work was designed to investigate the effects
of Rg5 on the regulation of lipolysis in hypoxic adipose tissue
with emphasis on the regulation of succinate accumulation and
the second messenger cAMP. Herein, we indicate that succinate
accumulated in the adipose tissue of high-fat diet (HFD) fedmice,
linking hypoxia and ER stress with lipolysis through NLRP3
inflammasome activation. Ginsenoside Rg5 inhibited succinate-
associated lipolysis by reducing cellular energy charge, and thus
ameliorated insulin resistance in the muscle by reducing lipid
deposits. These findings provide novel insights into the effect of
Rg5 on the regulation of glucose and lipid homeostasis.
MATERIALS AND METHODS
Reagents
Rg5 (purity > 95%) was purchased from Jiangsu Yongjian
Pharmaceutical Technology Co., Ltd. (Jiangsu, China).
Tauroursodeoxycholic Acid (TUDCA), dimethyl succinate,
dimethyl malonate, thapsigargin (TG), isobutylmethylxanthine
(IBMX), dexamethasone, insulin, and Ro-20-1724 were obtained
from Sigma (St Louis, MO, USA), while forskolin was from
Abcam Cambridge, USA. Palmitate (PA, Sinopharm, Shanghai,
China) was dissolved in ethanol to prepare 200 mM stock
solution and then diluted with medium containing 10% FFA-free
BSA at the ratio of 1:19 before use. The following items were
purchased from the cited commercial sources: anti-HIF-1α
antibody (PA1-16601) from Thermo Scientific; anti-IL-1β
antibody from R&D; anti-PERK (#3192), anti-phospho-
(Ser/Thr) PKA substrate (#9621), anti-phospho-HSL (Ser660)
(#4126), anti-HSL (#4107), anti-NLRP3 (#15101), and anti-
phospho-Akt (Thr308) (#8205) from Cell Signaling Technology
(Beverly, MA, USA); anti-phospho-IRE1α (S724) (ab104157),
anti-IRE1α (ab37073), and anti-cleaved caspase-1/anti-caspase-1
(ab1872) from Abcam; anti-phospho-PERK (Thr981) (sc-32577)
and anti-PDE3B (sc-20793) from Santa Cruz; anti-Akt (A444),
GADPH and Goat Anti-Rabbit IgG (H+L) HRP from Bioworld
Technology (St. Paul, MN, USA); Ciolostamide (B6500) from
ApexBio
Cell Culture and Differentiation
3T3-L1 (a cell line of preadipocyte, from ATCC) were cultured in
Dulbecco’s Minimum Essential Medium (DMEM, Gibco, USA)
supplemented with 10% FBS, 100 µg/mL of streptomycin and
100 U/mL of penicillin at 37◦C in a 5% CO2 atmosphere. The
cells were treated when grew to 80–90% confluence with DMEM
containing 0.5 mM IBMX, 1 mM dexamethasone, 10 µg/mL
insulin for 2 days. The cells were then incubated in DMEM
(10% FBS) containing 10 µg/mL insulin alone for another 2
days. Adipocytes were used 8–10 days after the initiation of
differentiation.
C2C12 mouse myoblasts obtained from the Type Culture
Collection of the Chinese Academy of Sciences (Shanghai,
China), were cultured in DMEM with 10% FBS. C2C12
myoblasts were grown to 80–90% confluence and then induced
to differentiate by changing the medium from 10% FBS to 2%
horse serum and left for up to 5 days. The medium was changed
every 2 days during the entire experimental period.
Animals
Male ICR mice (18–20 g) were supplied by the Laboratory
Animal Center of Nanjing Qinglongshan and were housed in
colony cages with 12:12 h light/dark cycles. All experiments and
animal care were conducted in accordance with the Provision
and General Recommendation of Chinese Experimental Animals
Administration Legislation and were approved by Animal Ethics
Committee of China Pharmaceutical University. For HFD study,
mice were fed with HFD (10% Lard, 10% yolk, 1% cholesterol,
0.2% cholate and 78.8% standard diet) for 10 days simultaneously
with administration of Rg5 or TUDCA (50 mg/kg) by oral gavage
every day. After being fasted, blood was collected from the orbital
sinus for biochemical assay using commercial kits (Jiancheng,
Nanjing, China).
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Preparation of Conditioned Medium (CM)
The fat located in the epididymis fromHFD fedmice was isolated
and chopped into small pieces and 100mg weight taken. The
prepared adipose tissue was incubated in 2 mL DMEM or KRH
buffer (Krebs-Ringer phosphate- HEPES buffer, containing 118-
mM NaCl, 5-mM KCl, 1.3-mM CaCl2, 1.2-mMMgSO4, 1.2-mM
KH2PO4, and 30-mM HEPES, containing 0.5% BSA, pH 7.4)
supplemented with 10% FBS for 16 h. Then, the supernatants
were collected by centrifugation as CM and stored at−70◦C.
Oral Glucose Load Test
After being fasted overnight, HFD-fed mice were administered
glucose solution (2 g/kg) orally. For CM challenge, normal mice
were fasted overnight and injected with CM (i.p. 0.1 mL /10 g) for
30 min before glucose load. Blood samples were collected from
the orbital sinus at regular intervals after glucose load, serum
glucose was tested with a commercial kit based on the glucose
oxidase peroxidase (GOD-POD)method. AUCwas calculated for
blood glucose as the following formula: 0.5× [Bg0+ Bg0.5]/2+
0.5 × [Bg0.5 + Bg1.0]/2 + 1 × [Bg1.0 + Bg2.0]/2 (Bg0, Bg0.5,
Bg1.0, and Bg2.0 referred to the blood glucose concentration at 0,
0.5, 1.0, and 2.0 h after the glucose load).
Pimonidazole Staining for Hypoxia
To detect hypoxia staining in adipose tissue, HFD-fed mice
were intraperitoneally injected with pimonidazole (60 mg/kg)
(Hypoxyprobe-1 plus kit, Hypoxyprobe, Inc., Burlington, USA)
prior to sacrifice. Adipose tissue located in the epididymis
was removed and fixed in 4% paraformaldehyde. The isolated
adipose tissue was dehydrated and embedded in paraffin and
then cut into thickness and affixed onto the slides. The slides
were immunostained with FITC-conjugated antibodies (1:100)
against pimonidazole adducts according to the manufacturer’s
instructions. For hypoxia detection in adipocytes, pimonidazole
(200 µM) was added into cells with the indicated agents,
and then incubated with palmitate (PA, 100 µM) for 8 h or
exposed to hypoxia (1% O2) for 4 h. Cells were fixed with 4%
paraformaldehyde and permeabilized with 0.3% Triton X-100 for
10 min and then blocked with 5% BSA for 1 h. After stained
with FITC-conjugated antibodies for 1 h at 37◦C, cells were
washed three times with PBS. The image was visualized using
fluorescence microscope.
Detection of Mitochondrial Complex I and
IV Activity
Differentiated adipocytes were cultured in 15 cm diameter plates
and treated with Rg5 (10 µM) or metformin (1 mM) for 4
h, and the cells were collected after PBS wash. Mitochondria
were isolated by Mitochondria Isolation Kit (Jiancheng, Nanjing,
China). Then, 10 µg of protein was collected for the assay
of complex I or IV activity with commercial kit (Jiancheng,
Nanjing, China). For ATP measurement, 3T3-L1 cells were
treated with regents for 4 h, the cells extracted with lysis
buffer, and centrifuged at 12 000 g for 15 min at 4◦C. After
quantification, the supernatants were detected by ATP Assay Kit
(Beyotime, Nanjing, China).
Oxygen Consumption Ratio (OCR)
Measurements
OCR measurement was done using the XFe96 Extracellular
Flux Analyzer (Seahorse Bioscience, North Billerica, MA, USA).
Differentiated adipocytes were seeded (104 cells/well) and
incubated overnight in DMEM supplemented with 10% FBS.
The cells were treated with Rg5 (10 µM) or metformin (1
mM) for 4 h. One hour before the measurement, the cells were
incubated with XF medium at 37◦C in a CO2-free incubator.
The OCR was detected under basal condition and after the
application of 1µMoligomycin, 0.5µMFCCP (carbonyl cyanide
p-trifluoromethoxyphenylhydrazone) and 0.5 µM rotenone +
0.5 µM antimycin A (XF Cell Q17 Mito Stress Test Kit; Seahorse
Bioscience). OCR result was analyzed using the Seahorse XF96
software. Each sample was analyzed four times.
Mitochondrial ROS Analysis
Adipocytes were pretreated with Rg5 (10 µM), TUDCA (100
µM), rotenone (1 µM) with or without PA (100 µM) for 8
h, and then incubated with MitoSox Red (5 µM, Molecular
Probes, Eugene, OR) andMito-Tracker Green (30 nM, Beyotime,
Shanghai, China) for 30 min. Labeled cells were analyzed by
confocal microscopy.
Succinate Quantification
Differentiated adipocytes (106) stimulated with PA or TG (1µM)
for 8 h or 10mg adipose tissue of HFD-fed mice were rapidly
homogenized on ice in 100 µL of ice-cold succinate assay buffer.
Centrifuge at 10,000 g for 5 min to collect the supernatant. The
supernatant was measured by succinate colorimetric assay kit
(Sigma, St Louis, USA) following the manufacturer’s instructions.
Phosphodiesterases (PDEs) and Succinate
Dehydrogenase (SDH) Activity in
Adipocytes
Differentiated adipocytes were stimulated with PA or dimethyl
succinate at given concentrations for 8 h. Cells were collected by
centrifugation. After washing with cold PBS, resuspend cells in
PBS were subjected to ultrasonication for four times, and then
centrifuged to remove cellular debris. The protein concentration
was determined by Bicinchoninic Acid Protein Assay kit. The
activity was measured by succinate dehydrogenase assay kit
(Jiancheng, Nanjing, China) or PDE activity assay kit (Abcam,
Cambridge, USA).
Measurement of Glycerol, Free Fatty Acids,
IL-6, TNF-α, and IL-1β
In vitro, differentiated adipocytes were cultured in serum-free
DMEM, and pretreated with indicated agents in the presence of
PA (100 µM) for 2 h. After washing, the cells were cultured for
another 6 h. In vivo, HFD-fed mice were sacrificed by cervical
dislocation. The epididymis adipose tissue was chopped into
small pieces and 100mg weight taken to and incubated in 2 mL
DMEM for 16 h. The supernatants were analyzed for glycerol
(Jiancheng, Nanjing, China) and free fatty acids (calvin, Suzhou,
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China) by commercial kits. IL-6, TNF-α and IL-1β in themedium
was determined using ELISA (Cusabio Biotech, Wuhan, China).
cAMP, AMP, Diacylglycerol (DAG) and
Ceramides Quantification
Differentiated adipocytes were collected, subjected to
ultrasonication and centrifuged to remove cellular debris.
Adipose tissues were rinsed and weighed before homogenization.
After homogenization, the resulting suspension was subjected
to ultrasonication and centrifugation. The contents of cAMP
(USCN, Wuhan, China) AMP (Chengbin Biotech, Shanghai,
China) in the supernatant were measured by ELISA following
the manufacturer’s instructions.
For HFD-fed mice, skeletal muscle was removed, weighed and
then homogenized in 0.9% NaCl (1: 9, v/v). For normal mice,
after treatment with CM (i.p. 1 ml/10 g) for 1 h, the skeletal
muscle was isolated and homogenized. After centrifugation, the
supernatant was measured for DAG and ceramides contents
using commercial kits (Calvin, Suzhou. China).
Immunohistochemistry for HSL
Differentiated adipocytes were stimulated with PA (100 µM) for
8 h fixed in 4% paraformaldehyde for 15 min, and then blocked
with 5% BSA containing 0.3% Triton X-100 for 1 h. The cells
were incubated with primary antibodies (1:100) overnight at
4◦C and probed with anti-Rabbit IgG-FITC for 1 h in the dark.
Immunofluorescent HSL signal was observed under a Nikon
Eclipse Ti-s microscope.
Detection of 2-NBDG Uptake by C2C12
Cells with Fluorescence Microscopy
After serum starvation, differentiated C2C12 cells were
stimulated with CM in KRH buffer for 30 min and then
incubated with 500 µM 2-NBDG (Invitrogen, Oregon, USA)
containing 100 nM insulin for another 30 min. Glucose uptake
was observed under fluorescence microscope.
Western Blot Analysis
Tissue or cell proteins were extracted with lysis buffer, the
lysates were centrifuged and the supernatants were collected.
For the assay of membrane PKCθ, membrane protein was
prepared with plasmamembrane protein extraction kit (KeyGEN
Biotech, Nanjing, China). The supernatants were quantified with
Bicinchoninic Acid Protein Assay kit (Biosky Biotechnology
Corporation, Nanjing, China). After quantification, 40 µg
protein samples were resolved by 10% SDS-PAGE and transferred
electrophoretically to PVDF membranes, blocked, and then
incubated with primary antibodies (1:1000) and secondary
antibody (1:1000). The antibody reactivity was then detected by
ECL and quantified by densitometry with IPP 6.0 software. The
assessment of HSL and JNK phosphorylation was performed
at the same time for the similar molecular weight of GAPDH
(36 kDa) and JNK (46 kDa). The protein expression levels of
GAPDH, HSL, and JNK were separately detected, and then HSL
and JNK phosphorylation were simultaneously detected on one
gel with consistent experimental conditions.
Statistics
Results were expressed as mean ± SD. For comparison between
the two groups, Student’s t-test was used. To compare more
than two groups, statistical analysis was performed by one-way
ANOVA followed by the Student’s t-test. Values of p < 0.05 were
considered statistically significant.
RESULTS
Rg5 Attenuated Hypoxia in Adipose Tissue
Short term-HFD feeding (10 days) in mice induced hypoxia in
adipose tissue, indicated by increased pimonidazole staining
and HIF-1α accumulation, whereas these alterations were
prevented by Rg5 or ER stress inhibitor TUDCA administration
(Figures 1A,B). Rg5 and TUDCA also inhibited HIF-1α
induction in adipocytes exposed to PA or hypoxia (1% O2)
treatment (Figures 1C,D). Meanwhile, Rg5 and TUDCA
treatment prevented low oxygen tension in adipocytes
(Figures 1E,F), suggesting that Rg5 inhibited HIF-1α
accumulation by preventing lower oxygen tension.
Rg5 Attenuated Hypoxia in Adipocytes by
Reducing Cellular Energy Charge
To know the possible mechanism through which Rg5 prevented
adipose hypoxia, we investigated the effects of Rg5 on cellular
energy charge in adipocytes. Rg5 inhibited the activity of complex
I and IV of the mitochondrial respiratory chain and reduced
oxygen consumption ratio (OCR) in adipocytes (Figures 2A–C).
Concordantly, Rg5 treatment effectively reduced intracellular
ATP levels with increased AMP accumulation (Figures 2D,E).
As a positive control, metformin exerted a similar effect
in adipocytes. Meanwhile, we observed that Rg5 inhibited
PA-induced mitochondrial ROS production in adipocytes
(Figure 2F). Mitochondrial complex I inhibitor rotenone
inhibited mitochondrial ROS generation, indicating that
inhibition ofmitochondrial complex I contributed to suppressing
mitochondrial ROS production. These results indicate that Rg5
and metformin reduced cellular energy charge by mild inhibition
of mitochondrial respiration in adipocytes.
Rg5 Suppressed ER Stress in Adipose
Tissue
As a cellular stress, hypoxia could induce ER stress. HFD
feeding increased the ER-localized protein sensor PERK and
IRE1α phosphorylation in adipose tissue, while ATF6 expression
was not affected (Figures 3A–C). Oral administration of
Rg5 and TUDCA inhibited PERK and IRE1α activation by
dephosphorylation without influence on ATF6 expression.
Similarly, Rg5 inhibited PA-induced PERK and IRE1α
phosphorylation in adipocytes without affecting ATF6 induction
(Figures 3D–F). These results indicate the inhibitory effect of
Rg5 on ER stress.
Rg5 Reduced Succinate Accumulation in
Adipose Tissue
HFD feeding led to succinate accumulation in adipose tissue,
and this alternation was prevented by Rg5 as well as TUDCA
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FIGURE 1 | Effects of Rg5 on adipose hypoxia. (A) Adipose hypoxia examination with pimonidazole staining in HFD mice. (B) HIF-1α protein expression in
adipose tissue of HFD-fed mice. (C,D) HIF-1α protein expression in differentiated adipocytes treated with palmitate (PA), 1% O2 for 8 h. (E,F) Pimonidazole staining in
differentiated adipocytes treated with PA for 8 h or 1% O2 for 4 h. The results were expressed as the mean ± SD of three independent experiments. *p < 0.05 vs.
Control (Ctr), #p < 0.05 vs. Blank. TU, Tauroursodeoxycholic Acid; Met, Metformin.
administration (Figure 4A). Meanwhile, Rg5 and TUDCA
reduced IL-1β production and protein levels of pro-IL-1β and
active IL-1β in adipose tissue (Figures 4B,C). Consistently, Rg5
as well as TUDCA reduced PA-induced succinate accumulation
in differentiated adipocytes (Figure 4D). Interestingly, SDH
inhibitor dimethyl malonate reduced succinate production,
suggesting that succinate accumulation is the result of SDH
activity reversal. To confirm this, we examined SDH activity in
the presence of PA and found that Rg5 inhibited PA-induced
SDH activation in adipocytes (Figure 4E). Aminooxyacetate
(AOA), an inhibitor of aspartate aminotransferase in the
malate/aspartate shuttle, inhibited SDH activity, indicating that
malate/aspartate shuttle contributed to the reversal of SDH
activity and subsequent succinate production (Figure 4E). TG
causes ER stress by modulating Ca2+ levels and is usually used
as an activator to induce ER stress. Rg5 reduced TG-induced
succinate production, suggesting that the inhibitory effect of Rg5
contributed to reducing succinate production (Figure 4F). Taken
together, these results indicated that Rg5 attenuated adipose
hypoxia and then reduced succinate accumulation in adipose
tissue. The proposed pathway for succinate production due to the
reversal of SDH activity was shown in Figure 4G.
Rg5 Blocked cAMP/PKA Signaling in
Adipose Tissue
HFD feeding increased cAMP accumulation (Figure 5A) with
reduced AMP contents (Figure 5B) in adipose tissue, and
these alternations were reversed by oral administration of Rg5
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FIGURE 2 | Rg5 reduced cellular energy charge in differentiated adipocytes. (A,B) Mitochondrial respiratory complex I and IV activity in differentiated
adipocytes (n = 3). (C) Oxygen consumption ratio (OCR) in differentiated adipocytes (n = 4). (D,E) ATP and AMP contents in differentiated adipocytes (n = 6). (F)
Mitochondrial ROS levels were measured by MitoSox Red (red) using confocal microscopy (n = 3). MitoSox Red was colocalized with MitoTracker Green. Scale bar,
20 µM. Data above were expressed as the mean ± SD. *p < 0.05 vs. Blank. TUDCA, Tauroursodeoxycholic Acid.
and TUDCA (Figures 5A,B). In line with the reduced cAMP
production, adipose PKA 62 KDa substrate phosphorylation
was attenuated in mice treated with Rg5 and TUDCA
(Figure 5C).
Similar to the regulation of cAMP in vivo, Rg5 reduced PA-
induced cAMP accumulation (Figure 5D) with increased AMP
contents (Figure 5E) in adipocytes. As an activator of adenylate
cyclase (AC), forskolin increased cAMP accumulation. Rg5
inhibited forskolin-induced cAMP accumulation (Figure 5F),
suggesting that the reduced cAMP production might be
related to the inhibition of AC activation by increased AMP.
Consistent with reduced cAMP accumulation, Rg5 and TUDCA
inhibited PA-induced PKA 62 KDa substrate phosphorylation in
adipocytes (Figure 5G).
Succinate Increased cAMP Accumulation
in Adipose Tissue
Intracellular cAMP is synthesized by AC and can be degraded
by phosphodiesterases (PDEs). In adipocytes, PDE inhibitor
IBMX and PDE3 inhibitor cilostamide, but not PDE4 inhibitor
Ro-20-1724, increased forskolin-induced cAMP production
(Figure 6A). The result indicated that PDE3 is the predominant
member of PDEs in adipocytes. PDE3A is more highly expressed
in the cardiovascular system, while PDE3B is more highly
expressed in adipocytes (Nilsson et al., 2006; Degerman et al.,
2011). Thus, we observed PDE3B expression in adipose tissue
of HFD-fed mice, and found that Rg5 and TUDCA preserved
PDE3B induction (Figure 6B), indicative of the contribution to
preventing cAMP accumulation.
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FIGURE 3 | Rg5 suppressed ER stress in adipose tissue. (A–C) PERK, IRE1α phosphorylations (n = 3) and ATF6 protein expression (n = 4) in adipose tissue of
HFD-fed mice. (D–F) PERK (n = 3), IRE1α (n = 4) phosphorylations and ATF6 (n = 4) protein expression in differentiated adipocytes incubated with palmitate (PA) for
8 h. The results were expressed as the mean ± SD. *p < 0.05 vs. Control (Ctr), #p < 0.05 vs. Blank. TU, Tauroursodeoxycholic Acid; oligo, oligomycin; rot, rotenone.
Consistently, Rg5 and TUDCA protected PDE3B expression
in adipocytes exposed to PA insult (Figure 6C). PA induced
succinate formation due to the reversal of SDH activity, and
therefore SDH inhibition reduced PA-mediated succinate
production (Figure 4D). SDH inhibitor dimethyl malonate
blocked the inhibitory effect of PA on PDE3B expression
(Figure 6D), while dimethyl succinate, a cell-permeable
derivative of succinate, reproduced PA action to inhibit
PDE3B expression, suggesting that PA action was mediated
by succinate (Figure 6D). Anti-IL-1β antibody diminished the
inhibitory effect of succinate on PDE3B expression (Figure 6D).
Meanwhile, we examined the effect of succinate on PDEs activity
in differentiated adipocytes and found that dimethyl succinate
exhibited inhibitory effect on PDEs activity (Figure 6E). PDE3
activity was inhibited by PDE inhibitor IBMX, while AC
activation could further increase cAMP content. However,
succinate failed to change the elevated levels of cAMP in the
presence of IBMX, indicating that it did not influence AC activity
(Supplementary Figure 1).
We hypothesized that succinate mediated PA action to
suppress PDE3B expression in a manner dependent on IL-
1β. To confirmed this, we observed IL-1β production in
adipocytes and found that both PA and succinate increased IL-
1β production (Figure 6F). SDH inhibitor dimethyl malonate
diminished the enhancing effect of PA on IL-1β production
(Figure 6F), suggesting the increased IL-1β production by PA
depended on succinate, at least in part. IL-1β maturation is
mediated through NLRP3 inflammasome activation. Succinate
increased NLRP3 and cleaved caspase-1 expression, indicating
the activation of NLRP3 inflammation (Figure 6G). Succinate
induced cAMP production and co-treatment with anti-IL-1β
antibody diminished the enhanced effects of PA and succinate on
cAMP production (Figure 6H). These results provided evidence
to support our hypothesis that succinate was a mediator
in PA action and increased cAMP accumulation via NLRP3
inflammasome activation.
Rg5 Inhibited FFAs Release and
Inflammation in Adipose Tissue
Lipolysis is initiated from cAMP/PKA signaling. Consistent with
reduced cAMP accumulation and suppressed PKA substrate
phosphorylation, oral administration of Rg5 and TUDCA
suppressed hormone-sensitive lipase (HSL) phosphorylation,
and then reduced FFAs and glycerol release from adipose tissue
in HFD-fed mice (Figures 7A–C), suggesting their inhibitory
effects on lipolysis. Similar to the regulation in vivo, Rg5 and
TUDCA also inhibited HSL translocation to the surface of
the lipid droplets, prevented PA-induced HSL phosphorylation
(Figures 7D,E) and reduced FFAs and glycerol release from
differentiated adipocytes (Supplementary Figure 2). Rg5 and
TUDCA attenuated JNK phosphorylation and reduced IL-6
production in the adipose tissue of HFD-fed mice, indicating
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FIGURE 4 | Rg5 reduced succinate accumulation in adipose tissue. (A,B) Succinate and IL-1β contents in adipose tissue of HFD mice (n = 6–8). (C) Protein
expression of pro-IL-1β and active IL-1β in adipose tissue was determined by immunoblot analysis (n = 3). (D,F) Succinate accumulation in differentiated adipocytes
treated with palmitate (PA) or thapsigargin (TG) for 8 h (n = 6). (E) SDH activity in differentiated adipocytes treated with PA for 8 h. (G) Summary of MAS pathway as
potential drivers for the reversal of succinate accumulation. The results were expressed as the mean ± SD (n = 4). *p < 0.05 vs. Control (Ctr), #p < 0.05 vs. Blank.
TU, Tauroursodeoxycholic Acid; AOA, aminooxyacetate; Mal, dimethyl malonate.
their anti-inflammatory activity (Figures 7F,G). In adipocytes,
Rg5 also effectively reduced PA-induced TNF-α and IL-6
production (Figures 7H,I). SDH inhibitor dimethyl malonate
inhibited PA-induced TNF-α and IL-6 production and anti-IL-1β
antibody diminished the enhancing effects of succinate on TNF-α
and IL-6 production (Figures 7H,I), indicating that succinate-
derived IL-1β was paramount in inflammation.
Rg5 Improved Glucose Tolerance in
HFD-fed Mice
HFD feeding led to elevated levels of FFAs, glycerol, and
total cholesterol in the blood, while the level of triglyceride
remained unchanged. Oral administration of Rg5 reduced the
elevated levels of blood FFAs and glycerol without affecting other
metabolic parameters, including food intake and body weight
gain in mice (Supplementary Figure 3).
Oral administration of Rg5 increased glucose disposal
after glucose load, leading to reduction in the total glucose
(Figure 8A). To confirm the beneficial effect was associated with
the regulation of adipose function, we prepared conditioned
medium (CM) by incubation of the adipose tissue of HFD-fed
mice, and then intraperitoneally injected normal mice by with
CM.We observed that the glucose tolerance was impaired in CM-
treated mice. The glucose intolerance was prevented when the
CM was derived from Rg5 or TUDCA-treated mice during HFD
feeding (Figure 8B). These results indicated that the beneficial
regulation of adipose function by Rg5 contributed to improving
glucose homeostasis.
Rg5 Reduced Lipid Deposits and Improved
Insulin Signaling in the Muscle
To disclose the potential relation between the increased
circulating FFAs and insulin resistance, we investigated
lipid deposits and insulin signaling in skeletal muscle. HFD
feeding increased DAG and ceramides contents in the
muscle (Figures 9A,B) and attenuated Akt phosphorylation
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FIGURE 5 | Rg5 blocked cAMP/PKA signaling. (A,B) cAMP and AMP contents in adipose tissue of HFD-fed mice (n = 8). (C) PKA phosphorylation in adipose
tissue of HFD-fed mice (n = 3). (D,E) cAMP and AMP contents in differentiated adipocytes incubated with palmitate (PA) for 8 h (n = 6). (F) cAMP contents in
differentiated adipocytes pretreated with agents for 4 h, and stimulated with forskolin for 0.5 h (n = 8). (G) PKA phosphorylation in differentiated adipocytes treated
with PA for 8 h (n = 3). The results were expressed as the mean ± SD. *p < 0.05 vs. Control (Ctr), #p < 0.05 vs. Blank. TU, Tauroursodeoxycholic Acid.
in response to glucose load (Figure 9C), indicating the
presence of insulin resistance. Oral administration of Rg5 or
TUDCA reduced DAG and ceramides contents and improved
insulin signaling by normalizing Akt phosphorylation in the
muscle.
To explore the contribution of trafficking FFAs to muscle
insulin resistance, we treated normal mice with HFD fat-derived
CM, and found that CM challenge increased DAG and ceramides
accumulation in the muscle with attenuated Akt phosphorylation
(Figures 9D–F). When the CM was prepared from the adipose
tissue of Rg5 or TUDCA-treated mice in HFD-feeding, these
alternations were prevented.
Incubation of muscle cells with HFD fat-derived CM
promoted PKCθ translocation to the cell membrane and
inhibited insulin-mediated glucose uptake in muscle cells, but
these changes were prevented when the CM was prepared from
Rg5-treated mice in the course of HFD feeding (Figures 9G,H).
These data suggest that Rg5 inhibited lipolysis in adipose tissue
and prevented insulin resistance in muscle by reducing lipid
deposits.
DISCUSSION
Succinate is a metabolic intermediate whereas in hypoxic adipose
tissue it acted as a metabolic signaling molecule mediating
PA action to induce inflammation-associated lipolysis. Rg5
ameliorated succinate-associated adipose dysfunction, inhibited
lipolysis, and prevented muscle insulin resistance, providing new
insight into the role of Rg5 in the regulation of lipid and glucose
homeostasis.
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FIGURE 6 | Succinate increased cAMP accumulation. (A) Differentiated adipocytes were incubated with 20 µM IBMX, 20 µM Cilostamide (PDE3Bi), or 50 µM
Ro-20-1724 (PDE4i) for 0.5 h. Cells were treated with 10 µM forskolin for 0.5 h, lysed, and total cellular cAMP assayed. (B,C) PDE3B expression in adipose tissue of
HFD-fed mice (n = 3) or in palmitate (PA)-treated adipocytes (n = 4) were determined with western blot. (D) PDE3B expression in PA- or succinate-treated
differentiated adipocytes (n = 3). (E) PDE activity in differentiated adipocytes incubated with succinate for 8 h (n = 4). (F) IL-1β contents in differentiated adipocytes
were determined with ELISA (n = 6). (G) NLRP3 and cleaved caspase-1 expression in differentiated adipocytes were determined with western blot (n = 3). (H) cAMP
contents in adipocytes were determined with ELISA (n = 6). The results were expressed as the mean ± SD. *p < 0.05 vs. Control (Ctr), #p < 0.05 vs. Blank. TU,
Tauroursodeoxycholic Acid; Mal, dimethyl malonate; Suc, dimethyl succinate.
In the present study, we showed that short-term HFD feeding
induced hypoxia in adipose tissue of mice. These results indicate
that adipose hypoxia is an early event in adipose dysfunction
and provide new insight into the impact of lipotoxicity. To
know the possible mechanism through which Rg5 prevented
adipose hypoxia, we investigated the effects of Rg5 on cellular
energy charge, a process associated with oxygen consumption.
Rg5 reduced intracellular ATP/AMP ratio, resulting in adipocytes
of low energy charge. The inhibitory effect on mitochondrial
complex I and IV activity should be the main cause for the
reduced energy charge. Since oxygen is consumed at complex IV,
the inhibitory effect of Rg5 on mitochondrial complex IV should
contribute to preventing adipose hypoxia by reducing oxygen
consumption. Rg5 reduced oxygen consumption in adipocytes,
providing evidence to support our hypothesis. As an anti-
diabetic agent, metformin reduces cellular energy by inhibiting
mitochondrial complex I (Foretz et al., 2010), and this action
is proposed to be instrumental in the prevention of hypoxia
in the kidney (Takiyama et al., 2011). Similarly, we observed
that metformin prevented hypoxia in adipocytes exposed to
1% O2 (Figure 1F). Based on above-mentioned evidence, it is
reasonable to believe that Rg5 prevented adipose hypoxia by
reducing cellular energy charge.
Although ER stress is associated with ischemic injury in
heart and brain (Thuerauf et al., 2006; Xin et al., 2014), its
action in hypoxic adipose tissue is little known. TUDCA is
a chemical chaperone with the ability to suppress ER stress
(Ozcan et al., 2006). HFD feeding as well as direct PA challenge
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FIGURE 7 | Rg5 inhibited FFAs release and inflammation in adipose tissue. (A) HSL phosphorylation in adipose tissue of HFD-fed mice (n = 3). (B,C) FFAs,
Glycerol release from adipose tissue of HFD-fed mice (n = 6–8). (D,E) HSL recruitment and phosphorylation in adipocytes treated with palmitate (PA) (n = 3) for 8 h.
(F,G) JNK expression (n = 3) and IL-6 (n = 6) contents in adipose tissue of HFD mice. (H,I) TNF-α and IL-6 contents in adipocytes (n = 6). GAPDH band was
duplicated for (A,F) as a result of the experiments having been performed at the same time. Data were expressed as the mean ± SD. *p < 0.05 vs. Control (Ctr), #p
< 0.05 vs. Blank. TU, Tauroursodeoxycholic Acid; Mal, dimethyl malonate.
decreased cellular oxygen tension with ER stress, while ER stress
inhibitor TUDCA attenuated cellular hypoxia and prevented
HIF-1α accumulation, indicating that ER stress was involved in
adipose hypoxia. HFD feeding or PA challenge induced PERK
and IRE1α branches activation without alternation of ATF6.
These results are also consistent with published studies, which
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FIGURE 8 | Rg5 improved glucose tolerance in HFD-fed mice. (A) Oral
glucose tolerance in HFD mice. (B) Oral glucose tolerance in normal mice
treated with CM. Data were expressed as the mean ± SD (n = 10). *p < 0.05
vs. Control (Ctr), #p < 0.05 vs. Blank. TU, Tauroursodeoxycholic Acid.
show that PERK and IRE1α activation is involved in adipose
dysfunction (da Luz et al., 2011; Tsutsumi et al., 2011; Li
et al., 2015). Rg5 attenuated hypoxia in adipocytes, and this
regulation should contribute to reducing stress burden and HIF-
1α induction. Therefore, our work suggests that cellular energy
limitation might be a possible way to prevent ER stress in adipose
dysfunction.
Adipose lipolysis cascades are initiated by cAMP/PKA
signaling. As a second messenger in cellular signal transduction,
cAMP mediates cellular response to stress. The levels of cAMP
are regulated by AC and PDEs: AC increases cAMP production
while the accumulated cAMP is degraded by PDEs. More than
40 years ago, adenosine nucleosides were found to inhibit
AC activity (Fain et al., 1972). Biguanides and metformin
are shown to suppress hepatic AC activity and reduce cAMP
concentration by elevating the levels of AMP (Miller et al.,
2013). Rg5 reduced cellular energy charge with increased AMP
production, and the elevated levels of AMP could contribute
to the suppression of AC activity and cAMP production.
Forskolin binds to and stimulates AC activity directly without the
regulation of G protein. Rg5 reduced forskolin-induced cAMP
production, further indicating that it inhibited AC activity via
reducing cellular energy charge, a regulation independent of G
protein.
Although the increased AMP content was able to prevent
cAMP production by inhibition of AC activity, this regulation
could not explain the effect of Rg5 on the preserved
PDE3B induction. Interestingly, we observed increased succinate
accumulation in the adipose tissue of HFD-fed mice. Succinate
is an intermediate metabolite of the CAC and plays a crucial
role in energy metabolism. In the CAC, the conventional
direction of SDH is for the formation of fumarate from
succinate, whereas during anaerobic metabolism SDH might
act in reverse to reduce fumarate to succinate (Taegtmeyer,
1978; Chouchani et al., 2014). In the present study, PA
challenge induced hypoxia in adipocytes and increased succinate
production with SDH activation. These results indicate the
converse role of SDH in the hypoxic adipocytes, since
activation of SDH operating in its conventional direction
should decrease succinate accumulation due to the formation
of fumarate. Inhibition of SDH activity with dimethyl malonate
reduced succinate accumulation (Figure 4D), further confirming
the converse role of SDH in succinate production. As an
inhibitor of malate/aspartate shuttle, AOA inhibited SDH
activity (Figure 4E), indicating that malate/aspartate shuttle
inhibition blocked the supply of fumarate for succinate formation
(Chouchani et al., 2014). Different from ischemic succinate
accumulation in the heart (Chouchani et al., 2014), our work
showed that saturated fatty acid induces succinate production
via increased mitochondrial energy charge. Hypoxia induced
ER stress and TG increased succinate accumulation (Figure 4F),
suggesting that ER stress exacerbated metabolic disorders in
hypoxic adipose tissue.
Adipose dysfunction is tightly associated with inflammation.
A recent study suggests that cellular succinate production
induced IL-1β expression in macrophages (Tannahill et al., 2013).
Consistent with this, we found that succinate promoted IL-1β
production in hypoxic adipocytes with NLRP3 inflammasome
activation. The NLRP3 inflammasome is a molecular platform
composed of NLRP3, the adaptor protein ASC and caspase-1,
and its action is to promote IL-1β maturation and secretion
through caspase-1 cleavage (Schroder and Tschopp, 2010).
Succinate directly increased NLRP3 and cleaved caspase-
1 induction, indicating NLRP3 inflammasome activation.
Therefore, our work indicates that succinate-induced IL-1β
secretion should be a result of NLRP3 inflammasome activation.
Consistent with a recent published study, the replacement of
saturated fatty acid for monounsaturated fatty acid in high
fat diet could ameliorate IL-1β-mediated adipose dysfunction
and insulin resistance in mice, highlighting the special role of
saturated acid in NLRP3 inflammasome activation (Finucane
et al., 2015). Succinate impaired PDE3B expression and inhibited
PDEs activity (Figures 6D,E), while neutralization of IL-1β with
anti-IL-1β antibody diminished its inhibitory effect on PDE3B
activation (Figure 6D), indicating that IL-1β was involved
in the impairment of PDE3B expression. Succinate-mediated
cAMP production was blocked by treatment with anti-IL-
1β antibody (Figure 6H), providing evidence to prove the
speculation. Because succinate was derived from PA-induced
metabolic dysregulation, these results indicated that succinate
mediated PA action to induce cAMP accumulation in an
inflammation-dependent way. In fact, inflammatory signaling
and pro-inflammatory cytokines have been shown to increase
cAMP accumulation by downregulation of PDE activity in
adipose tissue and liver (Zhang et al., 2002; Ke et al., 2015).
Moreover, our work suggests the possibility that succinate-
derived IL-1β might act as an initiator of inflammation in
adipose dysfunction. Indeed, we observed that TNF-α and
IL-6 produciton were blocked by neutralizing IL-1β with IL-1β
anti-body. It is well-established that obesity is a low grade
inflammation and saturated fatty acid palmitate could act as a
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FIGURE 9 | Rg5 reduced DAG and ceramide contents and improved insulin signaling in the muscle. (A,B) DAG and ceramide contents in the muscle of HFD
mice (n = 6–8). (C) Akt phosphorylation in response to glucose load in the muscle of HFD mice (western blot, n = 4). (D–F) Normal mice were injected with CM, DAG,
ceramide contents (n = 6–8) and glucose load-induced Akt phosphorylation (n = 5) in the muscle were determined with ELISA or western blot. (G,H) Differentiated
C2C12 myotubes were incubated with CM, and membrane PKCθ and glucose uptake were examined. Data were expressed as the mean ± SD (n = 3). *p < 0.05 vs.
Control (Ctr), #p < 0.05 vs. Blank. TU, Tauroursodeoxycholic Acid.
ligand for toll-like receptor 4 (TLR4) to induce inflammation
in adipocytes (Davis et al., 2009). Consistent with the published
studies, ginsenosides inhibited inflammation via suppression
of TLR4 activation in macrophages (Kim et al., 2012; Lee I.
A. et al., 2012) our work presented another regulation for Rg5
to ameliorate inflammation-mediated adipose dysfunction.
Although our work indicated that succinate acted as a metabolic
signaling linking altered metabolism with inflammation
in adipose tissue, the functional interaction with TLR4-
mediated adipose dysfunction is unknown. Succinate mediates
lipopolysaccharide-induced inflammation in macrophages,
suggesting the possibility in adipocytes (Tannahill et al.,
2013).
Rg5 inhibited cAMP/PKA activation and reduced lipolysis,
and this action should prevent lipid deposits and insulin signaling
impairment in muscle. We prepared conditioned medium (CM)
from the adipose tissue of HFD-fed mice to induce DAG
accumulation and PKCθ translocation in muscle, establishing
the functional connection between adipose lipolysis and muscle
insulin resistance. DAG/PKCθ activation is shown to induce
insulin resistance by impairing insulin signaling in muscle
(Szendroedi et al., 2014). DAG may activate different isoforms
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FIGURE 10 | The proposed working pathway for ginsenoside Rg5 action in hypoxic adipose tissue. Saturated fatty acid PA induces hypoxia with ER stress
in adipose tissue, and then increases succinate formation. Succinate promotes IL-1β production through NLRP3 inflammasome activation, and then induces
cAMP/PKA signaling by inactivation of PDE3B, leading to lipolysis. PA also decreases AMP concentration, and then increases cAMP accumulation. The release of
FFAs increases cytosolic DAG, PKC translocation, ceramide accumulation and inhibits insulin-mediated Akt phosphorylation, thus leading to insulin resistance in
muscle. Rg5 inhibits lipolysis by suppression of succinate accumulation in hypoxic adipocytes and thus prevents insulin resistance in muscle.
of PKC to impair insulin signaling (Madani et al., 2001). For
example, in hepatocytes, DAG could promote PKCǫ translocation
and induce hepatic insulin resistance (Samuel et al., 2004). The
different DAG species or competitive effects of specific DAG
species might be the reason for the activation of different PKC
isoforms in special cells (Madani et al., 2001). In addition to
DAG, increased FFAs supply can raise intracellular ceramides,
which induce inflammation-associated insulin resistance by
impairing insulin-mediated Akt activation in muscle (Chaurasia
and Summers, 2015; Ritter et al., 2015). Oral administration of
Rg5 inhibited lipolysis in HFD-fed mice and prevented lipid
deposits and PKCθ activation in muscle, and thus improved
insulin signaling and promoted glucose uptake in muscle cells.
These results indicated that inhibition of adipose lipolysis could
prevent muscle insulin resistance.
Our work indicates that ER stress, inflammation, and lipolysis
simultaneously occurred in adipose dysfunction, and succinate as
a key mediator linking these events. Ginsenoside Rg5 inhibited
succinate-associated lipolysis via reducing cellular energy charge,
and effectively prevented insulin resistance inmuscle by reducing
lipid deposits. The proposed mechanistic pathway was shown
in Figure 10. Although the beneficial effects of ginsenosides on
adipose function and insulin sensitivity have been documented
(Yu et al., 2015; Chen et al., 2016), we provides new insight
into the cellular basis for Rg5 in the regulation of lipid and
glucose homeostasis. Moreover, our work suggests that blocking
FFAs trafficking from adipose to muscle might be a potential
therapeutic strategy for the prevention of insulin resistance.
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